adding glp-1 to insulin GLP-1-based therapies for type 2 diabetes: from single, dual and triple agonists endogenous production and L-cell differentiation | Diabetology & Metabolic Syndrome GLP-1 for Weight Loss and

Results Patients with a high cumulative dose of GLP-1 agonist are associated with a higher risk of developing drug-induced pancreatitis associated with GLP-1 agonists, indicated by a statistically significant odds ratio

Reddys Laboratories, shared his thoughts: The launch of Colozo marks a significant milestone in our gastrointestinal portfolio in India and builds on our legacy of introducing novel, first-in-class therapies following the successful launch of BixiBat last year

For those who want to go deeper: JAMA Psychiatry (2025):- GLP-1 RAs & Mental Health Meta-Analysis: JAMA Psychiatry (2025):- Semaglutide & Alcohol Use Disorder RCT: eClinicalMedicine / The Lancet (2024):- 12-Month Neurological & Psychiatric Outcomes of Semaglutide: APA Monitor (2025):- Mental Health Effects of GLP-1 Drugs (accessible overview):

As revolutionary new weight-loss drugs turn consumers off ultraprocessed foods, the industry is on the hunt for new products.